A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc.
Pfizer
Karyopharm Therapeutics Inc
DL Analytics
NiKang Therapeutics, Inc.
Mabwell (Shanghai) Bioscience Co., Ltd.
Elucida Oncology
Advaxis, Inc.
Genexine, Inc.
Novartis
GlaxoSmithKline